Condition: Squamous Cell Carcinoma
Interventions: Drug: Levulan Kerastick; Device: blue light source; Other: participant satisfaction survey
Sponsors: Rhode Island Hospital; DUSA Pharmaceuticals, Inc.
Not yet recruiting - verified December 2016
http://ift.tt/2jCvbmR
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου